Search | SPARK Innovation Hub

added blog Other

2026-06-24 09:35:08 -

Gefitinib in Clinical Oncology: Efficacy, Safety, and Emerging Research Frontiers

What Is Gefitinib? Gefitinib is a small molecule, highly selective EGFR tyrosine kinase inhibitor (EGFR-TKI). It is primarily used for the treatment of non-small cell lung cancer (NSCLC) with activating EGFR mutations. Gefitinib functions as an EGFR inhibitor by selectively binding to the ATP-binding site of the EGFR tyrosine kinase domain. This binding prevents the autophosphorylation of...

0 Comments 0 Shares 65 Views